OXYNEO
OxyNeo Said to Cause New Wave of Oxycodone Abuse In Canada
Drug maker Purdue Pharma’s patent on Oxycontin recently expired, opening the door to wider distribution of generic oxycodone. Yet Canada’s Health Minister refuses to ban the opioid, concerned that increased government control might lead to more arbitrary drug legislation.
Will Canada’s New Oxycodone Formulation—OxyNeo—Solve the Prescription Pain Reliever Problem?
After years of negotiating, Purdue Pharmaceutical and the Canadian Government finally settled on a way to improve the abuse and addiction problem that exists with OxyContin. On March 1, 2012, the new formulation called OxyNeo hit the shelves of pharmacies across Canada.
NARCONON NEWS
Narconon Extends Hope to Africa with Grand Opening of Continental Center
Narconon Centers
•
Rustenburg, South Africa
Celebrating 56 Years of Saving Lives with the Narconon Program
News
•
International